Protecting lung cancer patients from COVID-19 – and learning from the experience
A study led by Dr. Nathaniel Bourganim tracked changes in treatment plans
Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19
Reformulated and patented version of well-known generic drug could prove to be a quick, safe and cost-effective way to accelerate recovery and prevent hospitalizations
The World Brain Death Project: New publication offers significant and unprecedented consensus on the question of when brain death occurs
Dr. Sam Shemie offers a reference standard for practices worldwide
Canada Research Chairs Program announces new and renewed chairs
Congratulations to five RI-MUHC researchers in the spring 2020 round!
Dr. Thomas Emmett Francoeur awarded the Prix Letondal
Pioneering work in child development recognized by the Association of Pediatricians of Quebec
At the heart of precision medicine
New translational collaboration aims to transform approach to heart muscle disease
COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study
Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality
COVID-19 Q&A: Tina Montreuil on helping children cope with anxiety
“It is not only what you say that matters, but what you do”
RI-MUHC researchers review diagnostic tests for COVID-19
Study published in the Annals of Internal Medicine
New gift promotes respect for children’s voices
$1.1 million donation supports an interdisciplinary project spearheaded by researcher Franco Carnevale